A. Sinclair Dunlop

Insider Reports History

Location
Crestwood, KY
Signature
/s/ David Watson, attorney-in-fact for Sinclair Dunlop
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by A. Sinclair Dunlop:

Company Role Class Num Shares Value Price $ Report Date Ownership
Apellis Pharmaceuticals, Inc. Director Common Stock 161,567 $3,817,828 $23.63 01 Jan 2026 Direct
Apellis Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 14,684 $0 $66.30 01 Jan 2026 Direct

Insider Reports Filed by A. Sinclair Dunlop

Symbol Company Period Transactions Value $ Form Type Role Filing Time
APLS Apellis Pharmaceuticals, Inc. 01 Jan 2026 2 $0 4 Director 05 Jan 2026, 16:39
APLS Apellis Pharmaceuticals, Inc. 30 Sep 2025 2 -$702,057 4 Director 02 Oct 2025, 16:02
APLS Apellis Pharmaceuticals, Inc. 19 Sep 2025 2 -$713,561 4 Director 19 Sep 2025, 21:17
APLS Apellis Pharmaceuticals, Inc. 24 Jun 2025 3 -$737,536 4 Director 15 Oct 2025, 20:12
APLS Apellis Pharmaceuticals, Inc. 01 Jan 2025 2 $0 4 Director 03 Jan 2025, 16:17
APLS Apellis Pharmaceuticals, Inc. 23 Sep 2024 2 +$60,674 4 Director 24 Sep 2024, 16:20
APLS Apellis Pharmaceuticals, Inc. 16 Sep 2024 2 -$1,340,597 4 Director 17 Sep 2024, 17:21
APLS Apellis Pharmaceuticals, Inc. 28 Jun 2024 2 +$11,871 4 Director 01 Jul 2024, 16:02
APLS Apellis Pharmaceuticals, Inc. 21 Jun 2024 2 -$1,451,835 4 Director 21 Jun 2024, 19:34
APLS Apellis Pharmaceuticals, Inc. 12 Apr 2024 2 +$19,785 4 Director 15 Apr 2024, 16:09
APLS Apellis Pharmaceuticals, Inc. 19 Mar 2024 1 -$1,068,161 4 Director 20 Mar 2024, 17:18
APLS Apellis Pharmaceuticals, Inc. 01 Jan 2024 2 +$344,075 4 Director 02 Jan 2024, 16:09
APLS Apellis Pharmaceuticals, Inc. 14 Dec 2023 2 +$82,754 4 Director 15 Dec 2023, 16:04
APLS Apellis Pharmaceuticals, Inc. 01 Dec 2023 1 -$1,467,240 4 Director 05 Dec 2023, 16:21
APLS Apellis Pharmaceuticals, Inc. 17 Nov 2023 1 -$444,620 4 Director 21 Nov 2023, 16:36
APLS Apellis Pharmaceuticals, Inc. 17 Nov 2023 1 -$1,176,000 4 Director 21 Nov 2023, 16:00
APLS Apellis Pharmaceuticals, Inc. 03 Apr 2023 1 -$37,025 4 Director 05 Apr 2023, 16:54
APLS Apellis Pharmaceuticals, Inc. 01 Mar 2023 1 -$32,665 4 Director 02 Mar 2023, 15:20
APLS Apellis Pharmaceuticals, Inc. 01 Feb 2023 1 -$26,305 4 Director 02 Feb 2023, 15:15
APLS Apellis Pharmaceuticals, Inc. 03 Jan 2023 1 -$25,350 4 Director 05 Jan 2023, 18:40
APLS Apellis Pharmaceuticals, Inc. 01 Jan 2023 2 $0 4 Director 04 Jan 2023, 16:35
APLS Apellis Pharmaceuticals, Inc. 01 Dec 2022 1 -$24,965 4 Director 02 Dec 2022, 15:30
APLS Apellis Pharmaceuticals, Inc. 01 Nov 2022 1 -$30,415 4 Director 03 Nov 2022, 16:28
APLS Apellis Pharmaceuticals, Inc. 08 Sep 2022 1 -$975,000 4 Director 08 Sep 2022, 16:38
APLS Apellis Pharmaceuticals, Inc. 25 Aug 2022 2 +$56,796 4 Director 26 Aug 2022, 16:06
APLS Apellis Pharmaceuticals, Inc. 16 Aug 2022 2 +$355,516 4 Director 17 Aug 2022, 17:08
APLS Apellis Pharmaceuticals, Inc. 11 Aug 2022 1 -$1,968,900 4 Director 12 Aug 2022, 16:57
APLS Apellis Pharmaceuticals, Inc. 21 Jul 2022 2 +$134,484 4 Director 22 Jul 2022, 16:01
APLS Apellis Pharmaceuticals, Inc. 27 Jun 2022 1 -$62,743 4 Director 29 Jun 2022, 16:18
APLS Apellis Pharmaceuticals, Inc. 23 Jun 2022 1 -$675,000 4 Director 24 Jun 2022, 17:15
APLS Apellis Pharmaceuticals, Inc. 22 Apr 2022 2 +$280,000 4 Director 25 Apr 2022, 21:35
APLS Apellis Pharmaceuticals, Inc. 01 Jan 2022 2 $0 4 Director 04 Jan 2022, 15:38
APLS Apellis Pharmaceuticals, Inc. 10 Sep 2021 2 +$96,516 4 Director 13 Sep 2021, 16:10
APLS Apellis Pharmaceuticals, Inc. 01 Jun 2021 3 $0 4 Director 02 Jun 2021, 16:23
APLS Apellis Pharmaceuticals, Inc. 18 May 2021 9 -$8,558,129 4 Director 20 May 2021, 16:53